Related Experiment Video
Updated: Aug 26, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Cost-Effectiveness of Pediatric Universal Screening for Familial Hypercholesterolemia in Argentina
María B Araujo1, María Clara Zerbino2
1Nutrition Department, Hospital Garrahan, Ciudad Autónoma de Buenos Aires, Argentina.
Insights
Universal screening for familial hypercholesterolemia in children is cost-effective in Argentina. Early diagnosis through this method significantly increases life-years gained, making it a valuable health technology.
Area of Science:
- Public Health
- Health Economics
- Pediatrics
Background:
- Familial hypercholesterolemia (FH) is an underdiagnosed genetic disorder leading to premature cardiovascular disease.
- Early diagnosis and treatment of FH can significantly reduce long-term health risks.
Purpose of the Study:
- To evaluate the cost-effectiveness of universal pediatric screening for FH in Argentina.
- To compare universal screening with the existing diagnostic approach.
Main Methods:
- A probabilistic model was used to compare universal screening at age 6 with the previous diagnostic situation.
- The study adopted the perspective of the Argentine public healthcare system, considering direct costs and life-years gained (LYG) and quality-adjusted life-years (QALYs).
- A 60-year time horizon was used, including avoided costs of prevented coronary events and sensitivity analyses.
Main Results:
- Each identified child gained an average of 8.14 life-years.
- The incremental cost-effectiveness ratio (ICER) was $1465.35 USD/LYG and $1726.50 USD/LYG at a 5% discount rate.
- The ICER represented 10%-17% of Argentina's per capita GDP and was below the minimum annual retirement income.
Conclusions:
- Pediatric universal screening for familial hypercholesterolemia is a cost-effective health technology in Argentina.
- Implementing universal screening can lead to significant improvements in life expectancy and quality of life.
Objective:
Our study aimed to evaluate the expected cost-effectiveness of pediatric universal screening for the early diagnosis of familial hypercholesterolemia in Argentina using a probabilistic model.
Methods:
Two different healthcare technologies were compared: (1) Universal screening of hypercholesterolemia at 6 years of age and (2) previous diagnostic situation (comparator). The perspective of the public Argentine healthcare system funded by the National Ministry of Health was used, considering only direct costs. Effectiveness was evaluated in terms of the number of life-years gained (LYG) and quality-adjusted life-years (QALYs) obtained by identifying familial hypercholesterolemia through each of the screening strategies. Only direct costs of screening and treatment of each strategy were evaluated. The time horizon was extended to 60 years. Future avoided costs of prevented coronary events were also included. Cost-effectiveness was measured in terms of the incremental cost-effectiveness ratio (ICER) per LYG and QALYs. Different scenarios were evaluated: (1) only index case, (2) index case and first-degree relatives, and (3) index case and first-degree relatives measuring QALYs. Sensitivity studies were conducted.
Results:
Each identified child complying with follow-up visits and treatment gains 8.14 life-years. The ICER values obtained were 1465.35 USD/LYG and 1726.50 USD/LYG when applying a discount rate of 5%. The ICER was 10%-17% of the gross domestic product per capita in Argentina (mean 2010-2019: 12 446 USD) and did not exceed the minimum annual retirement income.
Conclusion:
Pediatric universal screening for familial hypercholesterolemia could be considered a cost-effective health technology in Argentina.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Preventive Healthcare Services
Cholesterol: Significance and Regulation
Considering cholesterol and...

